Rocket Doctor Secures Funding to Drive U.S. Market Expansion and Product Innovation
Toronto, ON, Oct. 09, 2025 (GLOBE NEWSWIRE) -- Rocket Doctor AI Inc. (CSE: AIDR, OTC: AIRDF, Frankfurt: 939) (“Rocket Doctor AI”) today announced that its wholly-owned digital health platform and marketplace, Rocket Doctor Inc., is receiving advisory services and funding of up to $75,000 from the National Research Council of Canada Industrial Research Assistance Program (NRC IRAP) to develop secure communications functionality, and funding of up to $25,000 from the CanExport SMEs program to accelerate product innovation and U.S. market growth.
The NRC IRAP support will be dedicated to the development of a secure, PHIPA- and HIPAA-compliant messaging feature for Rocket Doctor’s care platform. This new capability will enable encrypted, real-time patient–clinician messaging for up to 5,000 concurrent users and a secure internal messaging system for over 500 clinicians. Designed to integrate seamlessly into Rocket Doctor’s workflows, the feature will align with Ontario Health’s Virtual Visit Solution standards, accelerate the company’s OTN certification timeline to Q1 2026, and position the platform for procurement by over 300 Ontario health service providers.
“This support enables us to accelerate development of secure, scalable communications technology that is essential for the future of healthcare,” said Dr. William Cherniak, Founder and CEO of Rocket Doctor Inc. “By ensuring our platform is fully compliant with PHIPA, HIPAA, and Ontario Health standards, we are not only serving Ontario patients, but also ensuring readiness across Canada, as well as for U.S. health systems, Medicaid / Medicare plans, and Commercial partners.”
Complementing this support is the CanExport contribution of $25,000 that will be used to accelerate Rocket Doctor’s U.S. expansion efforts, including the creation of professionally produced platform overview and case study videos, Spanish-language translation of its website and marketing materials, targeted online advertising in New York and California, and participation in key conferences to build partnerships with Medicaid managed care plans, hospitals, and Federally Qualified Health Centers (FQHCs).
These combined initiatives are expected to create new technical roles in Canada, enabling engineering resources to accelerate roadmap priorities, while increasing revenue potential through expanded eligibility for public procurement in Ontario and new deal flow in the United States. The secure-messaging platform enhancements will also increase adoption by equipping clinicians and patients with user-friendly communication tools that meet rigorous regulatory standards. Rocket Doctor’s growing software platform and expansion in the United States underscores its commitment to removing barriers to care, improving health equity, and leveraging Canadian innovation to solve cross-continental healthcare challenges.
About Rocket Doctor AI Inc.
Rocket Doctor AI Inc. delivers physician-built, AI-powered solutions designed to make high-quality healthcare accessible throughout the entire patient journey. A cornerstone of the company’s proprietary technology is the Global Library of Medicine (GLM), a clinically validated decision support system developed with input from hundreds of physicians worldwide.
Alongside the GLM is Rocket Doctor Inc, and its AI-powered digital health platform and marketplace. Having helped empower over 300 MDs to provide care to more than 700,000 patient visits, our proprietary technology software and systems enable doctors to independently launch and manage their own virtual or hybrid in-person practices - improving efficiency, restoring autonomy to MDs, and expanding patient access to care.
By reducing administrative burdens and ensuring greater consistency in care, our technology creates more time for meaningful physician-patient interactions. We are committed to reaching underserved, rural, and remote communities in Canada who often lack access to family doctors and supporting patients on Medicaid and Medicare in the United States. With advanced AI, large language models, and connected medical devices, Rocket Doctor AI is redefining modern healthcare - making it more scalable, equitable, and patient-centered.
To learn more about Rocket Doctor AI Inc’s products and services, contact:
www.rocketdoctor.ai or email: info@rocketdoctor.ai
FOR ADDITIONAL INFORMATION, CONTACT:
Dr. Essam Hamza, CEO, Rocket Doctor AI
essam.hamza@rocketdoctor.ai
Dr. Bill Cherniak, CEO, Rocket Doctor Inc.
bill@rocketdoctor.io
For media inquiries, contact: media@rocketdoctor.ai
Call: +1 (778) 819 8321
Cautionary Statements
This news release contains forward-looking statements relating to the future operations of Rocket Doctor AI Inc. and other statements that are not historical facts. Forward-looking statements are often identified by terms such as "will", "may", "should", "anticipate", "expects" and similar expressions. All statements other than statements of historical fact, included in this release, including, without limitation, statements regarding the Offering, the use of proceeds of the Offering, the filing of a Prospectus Supplement and future plans and objectives of Rocket Doctor AI Inc., are forward-looking statements that involve risks and uncertainties. There can be no assurance that such statements will prove to be accurate and actual results and future events could differ materially from those anticipated in such statements. Important factors that could cause actual results to differ materially from Rocket Doctor AI Inc.'s expectations include other risks detailed from time to time in the filings made by Rocket Doctor AI Inc. with securities regulators.
The reader is cautioned that assumptions used in the preparation of any forward-looking information may prove to be incorrect. Events or circumstances may cause actual results to differ materially from those predicted, as a result of numerous known and unknown risks, uncertainties, and other factors, many of which are beyond the control of Rocket Doctor AI Inc. The reader is cautioned not to place undue reliance on any forward-looking information. Such information, although considered reasonable by management at the time of preparation, may prove to be incorrect and actual results may differ materially from those anticipated. Forward-looking statements contained in this news release are expressly qualified by this cautionary statement. The forward-looking statements contained in this news release are made as of the date of this news release and Rocket Doctor AI Inc. will only update or revise publicly the included forward-looking statements as expressly required by Canadian securities law.
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
